{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T09:52:46Z","timestamp":1789811566311,"version":"4.0.1"},"reference-count":101,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1016\/j.vaccine.2021.01.032","type":"journal-article","created":{"date-parts":[[2021,1,22]],"date-time":"2021-01-22T08:48:22Z","timestamp":1611305302000},"page":"1225-1240","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":91,"title":["Variable seasonal influenza vaccine effectiveness across geographical regions, age groups and levels of vaccine antigenic similarity with circulating virus strains: A systematic review and meta-analysis of the evidence from test-negative design studies after the 2009\/10 influenza pandemic"],"prefix":"10.1016","volume":"39","author":[{"given":"G.N.","family":"Okoli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Racovitan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Abdulwahid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.H.","family":"Righolt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.M.","family":"Mahmud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2021.01.032_b0005","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.15585\/mmwr.mm6937a6","article-title":"Decreased influenza activity during the COVID-19 pandemic \u2014 United States, Australia, Chile, and South Africa, 2020","volume":"69","author":"Olsen","year":"2020","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.vaccine.2021.01.032_b0010","doi-asserted-by":"crossref","first-page":"C8","DOI":"10.1016\/j.vaccine.2008.04.011","article-title":"Vaccination and antigenic drift in influenza","volume":"26","author":"Boni","year":"2008","journal-title":"Vaccine"},{"issue":"5","key":"10.1016\/j.vaccine.2021.01.032_b0015","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1016\/j.vaccine.2009.11.043","article-title":"Epidemiological, antigenic and genetic characteristics of seasonal influenza A(H1N1), A(H3N2) and B influenza viruses: Basis for the WHO recommendation on the composition of influenza vaccines for use in the 2009\u20132010 Northern Hemisphere season","volume":"28","author":"Barr","year":"2010","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.vaccine.2021.01.032_b0020","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1378\/chest.12-1711","article-title":"Immunobiology of Influenza Vaccines","volume":"143","author":"Lorenzo","year":"2013","journal-title":"Chest"},{"issue":"17","key":"10.1016\/j.vaccine.2021.01.032_b0025","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.1016\/j.vaccine.2013.02.053","article-title":"The test-negative design for estimating influenza vaccine effectiveness","volume":"31","author":"Jackson","year":"2013","journal-title":"Vaccine"},{"issue":"5","key":"10.1016\/j.vaccine.2021.01.032_b0030","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1093\/aje\/kww064","article-title":"Theoretical Basis of the Test-Negative Study Design for Assessment of Influenza Vaccine Effectiveness","volume":"184","author":"Sullivan","year":"2016","journal-title":"Am J Epidemiol"},{"issue":"12","key":"10.1016\/j.vaccine.2021.01.032_b0035","doi-asserted-by":"crossref","first-page":"2686","DOI":"10.1093\/aje\/kwy163","article-title":"Measurement of Vaccine Direct Effects Under the Test-Negative Design","volume":"187","author":"Lewnard","year":"2018","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.vaccine.2021.01.032_b0040","doi-asserted-by":"crossref","unstructured":"Cumpston M, Li TJ, Page MJ, et al. Updated guidance for trusted systematic reviews: a new edition of the Cochrane Handbook for Systematic Reviews of Interventions. Cochrane Db Syst Rev. 2019;3;10:ED000142.","DOI":"10.1002\/14651858.ED000142"},{"key":"10.1016\/j.vaccine.2021.01.032_b0045","doi-asserted-by":"crossref","unstructured":"Moher D, Liberati A, Tetzlaff J, Altman DG, Group P. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Int J Surg. 2010;8(5):336-341.","DOI":"10.1016\/j.ijsu.2010.02.007"},{"key":"10.1016\/j.vaccine.2021.01.032_b0050","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.jclinepi.2016.01.021","article-title":"PRESS Peer Review of Electronic Search Strategies: 2015 Guideline Statement","volume":"75","author":"McGowan","year":"2016","journal-title":"J Clin Epidemiol"},{"issue":"11","key":"10.1016\/j.vaccine.2021.01.032_b0055","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1002\/sim.1186","article-title":"Quantifying heterogeneity in a meta-analysis","volume":"21","author":"Higgins","year":"2002","journal-title":"Stat Med"},{"issue":"1","key":"10.1016\/j.vaccine.2021.01.032_b0060","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1348\/000711010X522687","article-title":"Testing overall and moderator effects in random effects meta-regression","volume":"64","author":"Huizenga","year":"2011","journal-title":"Brit J Math Stat Psy"},{"issue":"2","key":"10.1016\/j.vaccine.2021.01.032_b0065","doi-asserted-by":"crossref","first-page":"143","DOI":"10.11613\/BM.2013.018","article-title":"The Chi-square test of independence","volume":"23","author":"McHugh","year":"2013","journal-title":"Biochem Medica"},{"issue":"7304","key":"10.1016\/j.vaccine.2021.01.032_b0070","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1136\/bmj.323.7304.101","article-title":"Systematic reviews in health care: Investigating and dealing with publication and other biases in meta-analysis","volume":"323","author":"Sterne","year":"2001","journal-title":"BMJ"},{"issue":"27","key":"10.1016\/j.vaccine.2021.01.032_b0075","doi-asserted-by":"crossref","first-page":"20851","DOI":"10.2807\/1560-7917.ES2014.19.27.20851","article-title":"Effectiveness of trivalent seasonal influenza vaccine in preventing laboratory-confirmed influenza in primary care in the United Kingdom: 2012\/13 end of season results","volume":"19","author":"Andrews","year":"2014","journal-title":"Euro Surveill"},{"issue":"8","key":"10.1016\/j.vaccine.2021.01.032_b0080","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1093\/infdis\/jit020","article-title":"Effectiveness of monovalent 2009 pandemic influenza A virus subtype H1N1 and 2010\u20132011 trivalent inactivated influenza vaccines in Wisconsin during the 2010\u20132011 influenza season","volume":"207","author":"Bateman","year":"2013","journal-title":"J Infect Dis"},{"issue":"2","key":"10.1016\/j.vaccine.2021.01.032_b0085","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.vaccine.2014.11.019","article-title":"Understanding influenza vaccine protection in the community: An assessment of the 2013 influenza season in Victoria Australia","volume":"33","author":"Carville","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2021.01.032_b0090","doi-asserted-by":"crossref","unstructured":"Castilla J, Mart\u00ednez-Baz I, Mart\u00ednez-Artola V, et al. Decline in influenza vaccine effectiveness with time after vaccination, Navarre, Spain, season 2011\/12. Eurosurveillance. 2013;18(5):20388.","DOI":"10.2807\/ese.18.05.20388-en"},{"issue":"11","key":"10.1016\/j.vaccine.2021.01.032_b0095","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1016\/j.vaccine.2016.01.054","article-title":"Effectiveness of subunit influenza vaccination in the 2014\u20132015 season and residual effect of split vaccination in previous seasons","volume":"34","author":"Castilla","year":"2016","journal-title":"Vaccine"},{"issue":"8","key":"10.1016\/j.vaccine.2021.01.032_b0100","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1016\/j.vaccine.2020.01.028","article-title":"Effectiveness of the current and prior influenza vaccinations in Northern Spain, 2018\u20132019","volume":"38","author":"Castilla","year":"2020","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2021.01.032_b0105","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1080\/21645515.2018.1514222","article-title":"Seasonal influenza vaccine effectiveness at primary care level, Hong Kong SAR, 2017\/2018 winter","volume":"15","author":"Chan","year":"2019","journal-title":"Hum Vacc Immunother"},{"key":"10.1016\/j.vaccine.2021.01.032_b0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.jvacx.2019.100011","article-title":"Effectiveness of the quadrivalent inactivated influenza vaccine in Japan during the 2015\u20132016 season: A test-negative case-control study comparing the results by real time PCR, virus isolation","volume":"1","author":"Chon","year":"2019","journal-title":"Vaccine X"},{"issue":"1","key":"10.1016\/j.vaccine.2021.01.032_b0115","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.vaccine.2015.11.016","article-title":"Assessment of influenza vaccine effectiveness in a sentinel surveillance network 2010\u201313 United States","volume":"34","author":"Cowling","year":"2016","journal-title":"Vaccine."},{"issue":"1","key":"10.1016\/j.vaccine.2021.01.032_b0120","doi-asserted-by":"crossref","first-page":"e0169528","DOI":"10.1371\/journal.pone.0169528","article-title":"Influenza vaccine effectiveness in the Netherlands from 2003\/2004 through 2013\/2014: The importance of circulating influenza virus types and subtypes","volume":"12","author":"Darvishian","year":"2017","journal-title":"PLoS ONE"},{"issue":"9","key":"10.1016\/j.vaccine.2021.01.032_b0125","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1017\/S0950268812002282","article-title":"Effectiveness of trivalent and monovalent influenza vaccines against laboratory-confirmed influenza infection in persons with medically attended influenza-like illness in Bavaria, Germany, 2010\/2011 season","volume":"141","author":"Englund","year":"2013","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.vaccine.2021.01.032_b0130","doi-asserted-by":"crossref","unstructured":"Fielding JE, Grant KA, Tran T, Kelly HA. Moderate influenza vaccine effectiveness in Victoria, Australia, 2011. Eurosurveillance. 2012;17(11):20115.","DOI":"10.2807\/ese.17.11.20115-en"},{"issue":"41","key":"10.1016\/j.vaccine.2021.01.032_b0135","doi-asserted-by":"crossref","first-page":"4905","DOI":"10.1016\/j.vaccine.2016.08.067","article-title":"Effectiveness of seasonal influenza vaccine in Australia, 2015: An epidemiological, antigenic and phylogenetic assessment","volume":"34","author":"Fielding","year":"2016","journal-title":"Vaccine"},{"issue":"12","key":"10.1016\/j.vaccine.2021.01.032_b0140","doi-asserted-by":"crossref","first-page":"2596","DOI":"10.1017\/S0950268814003677","article-title":"Influenza vaccine effectiveness estimates in Croatia in 2010\u20132011: a season with predominant circulation of A(H1N1)pdm09 influenza virus","volume":"143","author":"Filipovic","year":"2015","journal-title":"Epidemiol Infect"},{"issue":"11","key":"10.1016\/j.vaccine.2021.01.032_b0145","doi-asserted-by":"crossref","first-page":"1798","DOI":"10.1093\/cid\/ciy775","article-title":"Influenza Vaccine Effectiveness in the United States During the 2016\u20132017 Season","volume":"68","author":"Flannery","year":"2019","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.vaccine.2021.01.032_b0150","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1093\/infdis\/jiz543","article-title":"Spread of Antigenically Drifted Influenza A(H3N2) Viruses and Vaccine Effectiveness in the United States During the 2018\u20132019 Season","volume":"221","author":"Flannery","year":"2020","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2021.01.032_b0155","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1093\/infdis\/jiv577","article-title":"Influenza Vaccine Effectiveness Against 2009 Pandemic Influenza A(H1N1) Virus Differed by Vaccine Type During 2013\u20132014 in the United States","volume":"213","author":"Gaglani","year":"2016","journal-title":"J Infect Dis"},{"issue":"20","key":"10.1016\/j.vaccine.2021.01.032_b0160","doi-asserted-by":"crossref","first-page":"2371","DOI":"10.1016\/j.vaccine.2016.03.035","article-title":"Waning protection of influenza vaccine against mild laboratory confirmed influenza A(H3N2) and B in Spain, season 2014\u201315","volume":"34","author":"Gherasim","year":"2016","journal-title":"Vaccine"},{"issue":"6","key":"10.1016\/j.vaccine.2021.01.032_b0165","doi-asserted-by":"crossref","first-page":"e0179160","DOI":"10.1371\/journal.pone.0179160","article-title":"Grp cW. Effect of previous and current vaccination against influenza A(H1N1) pdm09, A(H3N2), and B during the post-pandemic period 2010\u20132016 in Spain","volume":"12","author":"Gherasim","year":"2017","journal-title":"PLoS ONE"},{"issue":"1","key":"10.1016\/j.vaccine.2021.01.032_b0170","doi-asserted-by":"crossref","first-page":"77","DOI":"10.4274\/balkanmedj.2017.0487","article-title":"Seasonal Influenza Vaccine Effectiveness in Preventing Laboratory Confirmed Influenza in 2014\u20132015 Season in Turkey: A Test-Negative Case Control Study","volume":"35","author":"Hekimoglu","year":"2018","journal-title":"Balk Med J"},{"issue":"4","key":"10.1016\/j.vaccine.2021.01.032_b0175","doi-asserted-by":"crossref","first-page":"e0122910","DOI":"10.1371\/journal.pone.0122910","article-title":"Effectiveness of the 2012\/13 trivalent live and inactivated influenza vaccines in children and adolescents in Saxony-Anhalt, Germany: A test-negative case-control study","volume":"10","author":"Helmeke","year":"2015","journal-title":"PLoS ONE"},{"issue":"6","key":"10.1016\/j.vaccine.2021.01.032_b0180","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1056\/NEJMoa1700153","article-title":"Influenza Vaccine Effectiveness in the United States during the 2015\u20132016 Season","volume":"377","author":"Jackson","year":"2017","journal-title":"New Engl J Med"},{"issue":"24","key":"10.1016\/j.vaccine.2021.01.032_b0185","doi-asserted-by":"crossref","first-page":"3595","DOI":"10.1016\/j.vaccine.2012.03.048","article-title":"Effectiveness of the 2010\u201311 seasonal trivalent influenza vaccine in Spain: cycEVA study","volume":"30","author":"Jimenez-Jorge","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2021.01.032_b0190","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1186\/1471-2334-13-441","article-title":"Effectiveness of influenza vaccine against laboratory-confirmed influenza, in the late 2011\u20132012 season in Spain, among population targeted for vaccination","volume":"13","author":"Jimenez-Jorge","year":"2013","journal-title":"BMC Infect Dis"},{"issue":"28","key":"10.1016\/j.vaccine.2021.01.032_b0195","first-page":"21187","article-title":"Estimating influenza vaccine effectiveness in Spain using sentinel surveillance data. Euro surveillance : bulletin Europ\u00e9en sur les maladies transmissibles =","volume":"20","author":"Jimenez-Jorge","year":"2015","journal-title":"European Communicable Dis Bullet"},{"issue":"29","key":"10.1016\/j.vaccine.2021.01.032_b0200","doi-asserted-by":"crossref","first-page":"3276","DOI":"10.1016\/j.vaccine.2015.03.051","article-title":"Interim influenza vaccine effectiveness: A good proxy for final estimates in Spain in the seasons 2010\u20132014","volume":"33","author":"Jimenez-Jorge","year":"2015","journal-title":"Vaccine."},{"issue":"5","key":"10.1016\/j.vaccine.2021.01.032_b0205","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1111\/irv.12018","article-title":"Moderate influenza vaccine effectiveness with variable effectiveness by match between circulating and vaccine strains in Australian adults aged 20\u201364years, 2007\u20132011","volume":"7","author":"Kelly","year":"2013","journal-title":"Influenza Other Resp"},{"issue":"2","key":"10.1016\/j.vaccine.2021.01.032_b0210","doi-asserted-by":"crossref","first-page":"76","DOI":"10.5694\/mja15.01017","article-title":"Influenza vaccine effectiveness in general practice and in hospital patients in Victoria, 2011\u20132013","volume":"204","author":"Kelly","year":"2016","journal-title":"Med J Aust"},{"issue":"47","key":"10.1016\/j.vaccine.2021.01.032_b0215","doi-asserted-by":"crossref","first-page":"6312","DOI":"10.1016\/j.vaccine.2014.08.066","article-title":"Influenza vaccine effectiveness estimates for Western Australia during a period of vaccine and virus strain stability, 2010 to 2012","volume":"32","author":"Levy","year":"2014","journal-title":"Vaccine."},{"issue":"3","key":"10.1016\/j.vaccine.2021.01.032_b0220","doi-asserted-by":"crossref","first-page":"e58222","DOI":"10.1371\/journal.pone.0058222","article-title":"Surveillance and Vaccine Effectiveness of an Influenza Epidemic Predominated by Vaccine-Mismatched Influenza B\/Yamagata-Lineage Viruses in Taiwan, 2011\u201312 Season","volume":"8","author":"Lo","year":"2013","journal-title":"PLoS ONE"},{"issue":"10","key":"10.1016\/j.vaccine.2021.01.032_b0225","doi-asserted-by":"crossref","first-page":"2379","DOI":"10.1080\/21645515.2017.1359364","article-title":"Influenza vaccine effectiveness against medically attended influenza illness in Beijing, China, 2014\/15 season","volume":"13","author":"Ma","year":"2017","journal-title":"Hum Vacc Immunother."},{"key":"10.1016\/j.vaccine.2021.01.032_b0230","doi-asserted-by":"crossref","unstructured":"Mart\u00ednez-Baz I, Mart\u00ednez-Artola V, Reina G, et al. Effectiveness of the trivalent influenza vaccine in Navarre, Spain, 2010-2011: A population-based test-negative case-control study. BMC Public Health. 2013;13(1):191.","DOI":"10.1186\/1471-2458-13-191"},{"issue":"7","key":"10.1016\/j.vaccine.2021.01.032_b0235","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1080\/21645515.2015.1038002","article-title":"Influenza vaccine effectiveness in preventing inpatient and outpatient cases in a season dominated by vaccine-matched influenza B virus","volume":"11","author":"Martinez-Baz","year":"2015","journal-title":"Human Vacc Immunotherapeut"},{"issue":"7","key":"10.1016\/j.vaccine.2021.01.032_b0240","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1093\/infdis\/jiz266","article-title":"Remaining Effect of Influenza Vaccines Received in Prior Seasons","volume":"220","author":"Martinez-Baz","year":"2019","journal-title":"J Infect Dis."},{"issue":"3","key":"10.1016\/j.vaccine.2021.01.032_b0245","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1111\/irv.12305","article-title":"Effectiveness and knowledge, attitudes and practices of seasonal influenza vaccine in primary healthcare settings in South Africa, 2010\u20132013","volume":"9","author":"McAnerney","year":"2015","journal-title":"Influenza Other Resp"},{"issue":"2","key":"10.1016\/j.vaccine.2021.01.032_b0250","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1111\/irv.12436","article-title":"Estimating vaccine effectiveness in preventing laboratory-confirmed influenza in outpatient settings in South Africa, 2015","volume":"11","author":"McAnerney","year":"2017","journal-title":"Influenza Other Resp"},{"issue":"10","key":"10.1016\/j.vaccine.2021.01.032_b0255","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1093\/infdis\/jiu647","article-title":"Influenza Vaccine Effectiveness in the United States During 2012\u20132013: Variable Protection by Age and Virus Type","volume":"211","author":"McLean","year":"2015","journal-title":"J Infect Dis"},{"issue":"1","key":"10.1016\/j.vaccine.2021.01.032_b0260","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1017\/S0950268817002709","article-title":"Estimating vaccine effectiveness against laboratory-confirmed influenza among children and adolescents in Lower Saxony and Saxony-Anhalt, 2012\u20132016","volume":"146","author":"Mohl","year":"2018","journal-title":"Epidemiol Infect"},{"issue":"35","key":"10.1016\/j.vaccine.2021.01.032_b0265","doi-asserted-by":"crossref","first-page":"4443","DOI":"10.1016\/j.vaccine.2014.06.053","article-title":"Estimates of 2012\/13 influenza vaccine effectiveness using the case test-negative control design with different influenza negative control groups","volume":"32","author":"Nunes","year":"2014","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.vaccine.2021.01.032_b0270","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1093\/cid\/cit736","article-title":"Influenza vaccine effectiveness in the 2011\u20132012 season: Protection against each circulating virus and the effect of prior vaccination on estimates","volume":"58","author":"Ohmit","year":"2014","journal-title":"Clin Infect Dis"},{"issue":"03","key":"10.1016\/j.vaccine.2021.01.032_b0275","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1017\/S0950268812001148","article-title":"Age-specific vaccine effectiveness of seasonal 2010\/2011 and pandemic influenza A (H1N1) 2009 vaccines in preventing influenza in the United Kingdom","volume":"141","author":"Pebody","year":"2013","journal-title":"Epidemiol Infect"},{"issue":"5","key":"10.1016\/j.vaccine.2021.01.032_b0280","doi-asserted-by":"crossref","DOI":"10.2807\/ese.18.05.20389-en","article-title":"Vaccine effectiveness of 2011\/12 trivalent seasonal influenza vaccine in preventing laboratory-confirmed influenza in primary care in the United Kingdom: Evidence of waning intra-seasonal protection","volume":"18","author":"Pebody","year":"2013","journal-title":"Eurosurveillance"},{"issue":"36","key":"10.1016\/j.vaccine.2021.01.032_b0285","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES.2015.20.36.30013","article-title":"Effectiveness of seasonal influenza vaccine in preventing laboratory-confirmed influenza in primary care in the United Kingdom: 2014\/15 end of season results","volume":"20","author":"Pebody","year":"2015","journal-title":"Eurosurveillance"},{"issue":"38","key":"10.1016\/j.vaccine.2021.01.032_b0290","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES.2016.21.38.30348","article-title":"Effectiveness of seasonal influenza vaccine for adults and children in preventing laboratory-confirmed influenza in primary care in the United Kingdom: 2015\/16 end-ofseason results","volume":"21","author":"Pebody","year":"2016","journal-title":"Eurosurveillance"},{"issue":"44","key":"10.1016\/j.vaccine.2021.01.032_b0295","doi-asserted-by":"crossref","first-page":"10","DOI":"10.2807\/1560-7917.ES.2017.22.44.17-00306","article-title":"End-of-season influenza vaccine effectiveness in adults and children, United Kingdom, 2016\/17","volume":"22","author":"Pebody","year":"2017","journal-title":"Eurosurveillance"},{"issue":"31","key":"10.1016\/j.vaccine.2021.01.032_b0300","doi-asserted-by":"crossref","first-page":"23","DOI":"10.2807\/1560-7917.ES.2019.24.31.1800488","article-title":"End of season influenza vaccine effectiveness in adults and children in the United Kingdom in 2017\/18","volume":"24","author":"Pebody","year":"2019","journal-title":"Eurosurveillance"},{"issue":"3","key":"10.1016\/j.vaccine.2021.01.032_b0305","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.vaccine.2019.10.071","article-title":"End of season influenza vaccine effectiveness in primary care in adults and children in the United Kingdom in 2018\/19","volume":"38","author":"Pebody","year":"2020","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.vaccine.2021.01.032_b0310","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.vaccine.2015.11.073","article-title":"Influenza vaccine effectiveness for hospital and community patients using control groups with and without non-influenza respiratory viruses detected, Auckland, New Zealand 2014","volume":"34","author":"Pierse","year":"2016","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.vaccine.2021.01.032_b0315","first-page":"127","article-title":"Influenza vaccine effectiveness to prevent medically attended laboratory confirmed influenza during season 2010\u20132011 in Romania: a case control study","volume":"20","author":"Pitigoi","year":"2012","journal-title":"Rev Romana Med Lab"},{"issue":"1","key":"10.1016\/j.vaccine.2021.01.032_b0320","first-page":"9","article-title":"Circulating influenza viruses and the effectiveness of seasonal influenza vaccine in Romania, season 2012\u20132013\/Virusurile gripale circulante \u0219i eficacitatea vaccinului gripal sezonier \u00een Rom\u00e2nia, \u00een sezonul 2012\u20132013","volume":"23","author":"Pitigoi","year":"2015","journal-title":"Romanian Rev Lab Med"},{"issue":"2","key":"10.1016\/j.vaccine.2021.01.032_b0325","first-page":"598","article-title":"Estimate of the Effectiveness of Influenza Vaccine among Children for the 2017\u20132018 Season","volume":"67","author":"Powell","year":"2019","journal-title":"J Invest Med"},{"issue":"3","key":"10.1016\/j.vaccine.2021.01.032_b0330","doi-asserted-by":"crossref","first-page":"e0149916","DOI":"10.1371\/journal.pone.0149916","article-title":"Detailed report on 2014\/15 influenza virus characteristics, and estimates on influenza virus vaccine effectiveness from Austria's sentinel physician surveillance network","volume":"11","author":"Redlberger-Fritz","year":"2016","journal-title":"PLoS ONE"},{"issue":"5","key":"10.1016\/j.vaccine.2021.01.032_b0335","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/j.vaccine.2018.12.006","article-title":"Estimating influenza vaccine effectiveness using data routinely available in electronic primary care records","volume":"37","author":"Regan","year":"2019","journal-title":"Vaccine"},{"issue":"19","key":"10.1016\/j.vaccine.2021.01.032_b0340","doi-asserted-by":"crossref","first-page":"2634","DOI":"10.1016\/j.vaccine.2019.02.027","article-title":"Intraseason decline in influenza vaccine effectiveness during the 2016 southern hemisphere influenza season: A test-negative design study and phylogenetic assessment","volume":"37","author":"Regan","year":"2019","journal-title":"Vaccine"},{"issue":"27","key":"10.1016\/j.vaccine.2021.01.032_b0345","doi-asserted-by":"crossref","first-page":"3102","DOI":"10.1016\/j.vaccine.2016.04.072","article-title":"Influenza vaccine effectiveness in Italy: Age, subtype-specific and vaccine type estimates 2014\/15 season","volume":"34","author":"Rizzo","year":"2016","journal-title":"Vaccine"},{"issue":"11","key":"10.1016\/j.vaccine.2021.01.032_b0350","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1093\/cid\/ciz075","article-title":"Effects of Influenza Vaccination in the United States During the 2017\u20132018 Influenza Season","volume":"69","author":"Rolfes","year":"2019","journal-title":"Clin Infect Dis"},{"issue":"35","key":"10.1016\/j.vaccine.2021.01.032_b0355","doi-asserted-by":"crossref","first-page":"4404","DOI":"10.1016\/j.vaccine.2014.06.063","article-title":"Higher vaccine effectiveness in seasons with predominant circulation of seasonal influenza A(H1N1) than in A(H3N2) seasons: Test-negative case-control studies using surveillance data, Spain, 2003\u20132011","volume":"32","author":"Savulescu","year":"2014","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.vaccine.2021.01.032_b0360","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1093\/cid\/cis431","article-title":"A sentinel platform to evaluate influenza vaccine effectiveness and new variant circulation, Canada 2010\u20132011 season","volume":"55","author":"Skowronski","year":"2012","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.vaccine.2021.01.032_b0365","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1093\/infdis\/jiu048","article-title":"Influenza A\/subtype and B\/lineage effectiveness estimates for the 2011\u20132012 trivalent vaccine: Cross-season and cross-lineage protection with unchanged vaccine","volume":"210","author":"Skowronski","year":"2014","journal-title":"J Infect Dis"},{"issue":"3","key":"10.1016\/j.vaccine.2021.01.032_b0370","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0092153","article-title":"Low 2012\u201313 Influenza Vaccine Effectiveness Associated with Mutation in the Egg-Adapted H3N2 Vaccine Strain Not Antigenic Drift in Circulating Viruses","volume":"9","author":"Skowronski","year":"2014","journal-title":"PLoS ONE"},{"issue":"5","key":"10.1016\/j.vaccine.2021.01.032_b0375","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1093\/infdis\/jiv177","article-title":"Integrated Sentinel Surveillance Linking Genetic, Antigenic, and Epidemiologic Monitoring of Influenza Vaccine-Virus Relatedness and Effectiveness During the 2013\u20132014 Influenza Season","volume":"212","author":"Skowronski","year":"2015","journal-title":"J Infect Dis"},{"issue":"1","key":"10.1016\/j.vaccine.2021.01.032_b0380","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1093\/cid\/ciw176","article-title":"A Perfect Storm: Impact of Genomic Variation and Serial Vaccination on Low Influenza Vaccine Effectiveness During the 2014\u20132015 Season","volume":"63","author":"Skowronski","year":"2016","journal-title":"Clin Infect Dis"},{"issue":"12","key":"10.1016\/j.vaccine.2021.01.032_b0385","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1093\/infdis\/jix526","article-title":"Beyond Antigenic Match: Possible Agent-Host and Immuno-epidemiological Influences on Influenza Vaccine Effectiveness During the 2015\u20132016 Season in Canada","volume":"216","author":"Skowronski","year":"2017","journal-title":"J Infect Dis"},{"issue":"46","key":"10.1016\/j.vaccine.2021.01.032_b0390","doi-asserted-by":"crossref","first-page":"39","DOI":"10.2807\/1560-7917.ES.2019.24.46.1900585","article-title":"Paradoxical clade- and age-specific vaccine effectiveness during the 2018\/19 influenza A(H3N2) epidemic in Canada: potential imprint-regulated effect of vaccine (I-REV)","volume":"24","author":"Skowronski","year":"2019","journal-title":"Eurosurveillance"},{"issue":"9","key":"10.1016\/j.vaccine.2021.01.032_b0395","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1093\/cid\/cix1013","article-title":"Seasonal Influenza Vaccine Effectiveness in Preventing Laboratory-Confirmed Influenza in Primary Care in Israel, 2016\u20132017 Season: Insights Into Novel Age-Specific Analysis","volume":"66","author":"Stein","year":"2018","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2021.01.032_b0400","doi-asserted-by":"crossref","unstructured":"Sullivan SG, Kelly H. Late season interim estimates of influenza vaccine effectiveness reliably predict end of season estimates in Victoria, Australia, 2007 to 2012. Euro surveillance : bulletin Europ\u00e9en sur les maladies transmissibles = European communicable disease bulletin. 2013;18(41):20605.","DOI":"10.2807\/1560-7917.ES2013.18.41.20605"},{"issue":"6","key":"10.1016\/j.vaccine.2021.01.032_b0405","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1002\/jmv.23847","article-title":"Influenza vaccine effectiveness during the 2012 influenza season in Victoria, Australia: Influences of waning immunity and vaccine match","volume":"86","author":"Sullivan","year":"2014","journal-title":"J Med Virol"},{"key":"10.1016\/j.vaccine.2021.01.032_b0410","doi-asserted-by":"crossref","unstructured":"Suzuki M, Minh LN, Yoshimine H, et al. Vaccine effectiveness against medically attended laboratory-confirmed influenza in Japan, 2011-2012 season. PLoS ONE. 2014;9(2):e88813.","DOI":"10.1371\/journal.pone.0088813"},{"issue":"7","key":"10.1016\/j.vaccine.2021.01.032_b0415","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1093\/cid\/cis574","article-title":"Effectiveness of seasonal influenza vaccines in the United States during a season with circulation of all three vaccine strains","volume":"55","author":"Treanor","year":"2012","journal-title":"Clin Infect Dis"},{"issue":"21","key":"10.1016\/j.vaccine.2021.01.032_b0420","doi-asserted-by":"crossref","first-page":"2831","DOI":"10.1016\/j.vaccine.2017.04.012","article-title":"Influenza Vaccine Effectiveness Estimates in the Dutch Population from 2003 to 2014: The Test-Negative Design Case-Control Study with Different Control Groups","volume":"35","author":"Van Doorn","year":"2017","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.vaccine.2021.01.032_b0425","doi-asserted-by":"crossref","first-page":"431.e5","DOI":"10.1016\/j.cmi.2017.09.003","article-title":"Estimation of seasonal influenza vaccine effectiveness using data collected in primary care in France: comparison of the test-negative design and the screening method","volume":"24","author":"Vilcu","year":"2018","journal-title":"Clin Microbiol Infec"},{"issue":"21","key":"10.1016\/j.vaccine.2021.01.032_b0430","doi-asserted-by":"crossref","first-page":"2460","DOI":"10.1016\/j.vaccine.2016.03.056","article-title":"Seasonal influenza vaccine effectiveness against medically attended influenza illness among children aged 6\u201359 months, October 2011\u2013September 2012: A matched test-negative case\u2013control study in Suzhou China","volume":"34","author":"Wang","year":"2016","journal-title":"Vaccine"},{"issue":"38","key":"10.1016\/j.vaccine.2021.01.032_b0435","doi-asserted-by":"crossref","first-page":"5774","DOI":"10.1016\/j.vaccine.2018.07.077","article-title":"Influenza vaccine effectiveness in preventing laboratory-confirmed influenza in outpatient settings: A test-negative case-control study in Beijing, China, 2016\/17 season","volume":"36","author":"Wu","year":"2018","journal-title":"Vaccine"},{"issue":"41","key":"10.1016\/j.vaccine.2021.01.032_b0440","doi-asserted-by":"crossref","first-page":"5285","DOI":"10.1016\/j.vaccine.2014.07.083","article-title":"Influenza vaccine effectiveness against medically-attended influenza illness during the 2012\u20132013 season in Beijing China","volume":"32","author":"Yang","year":"2014","journal-title":"Vaccine"},{"issue":"7","key":"10.1016\/j.vaccine.2021.01.032_b0445","doi-asserted-by":"crossref","first-page":"27","DOI":"10.2807\/1560-7917.ES.2018.23.7.17-00026","article-title":"Effectiveness of influenza vaccine in preventing medically-attended influenza virus infection in primary care, Israel, influenza seasons 2014\/15 and 2015\/16","volume":"23","author":"Yaron-Yakoby","year":"2018","journal-title":"Eurosurveillance"},{"issue":"12","key":"10.1016\/j.vaccine.2021.01.032_b0450","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1093\/cid\/ciw635","article-title":"2014\u20132015 Influenza Vaccine Effectiveness in the United States by Vaccine Type","volume":"63","author":"Zimmerman","year":"2016","journal-title":"Clin Infect Dis"},{"issue":"10","key":"10.1016\/j.vaccine.2021.01.032_b0455","doi-asserted-by":"crossref","first-page":"0139958","DOI":"10.1371\/journal.pone.0139958","article-title":"Assessing Antigenic Drift of Seasonal Influenza A(H3N2) and A(H1N1)pdm09 Viruses","volume":"10","author":"Tewawong","year":"2015","journal-title":"PLoS ONE"},{"issue":"2","key":"10.1016\/j.vaccine.2021.01.032_b0460","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1001\/jama.289.2.179","article-title":"Mortality associated with influenza and respiratory syncytial virus in the United States","volume":"289","author":"Thompson","year":"2003","journal-title":"Jama-J Am Med Assoc"},{"issue":"8","key":"10.1016\/j.vaccine.2021.01.032_b0465","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1080\/21645515.2018.1462639","article-title":"H3N2 influenza viruses in humans: Viral mechanisms, evolution, and evaluation","volume":"14","author":"Allen","year":"2018","journal-title":"Hum Vacc Immunother"},{"issue":"7","key":"10.1016\/j.vaccine.2021.01.032_b0470","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1093\/infdis\/jiw181","article-title":"Enhanced Genetic Characterization of Influenza A(H3N2) Viruses and Vaccine Effectiveness by Genetic Group, 2014\u20132015","volume":"214","author":"Flannery","year":"2016","journal-title":"J Infect Dis"},{"issue":"8","key":"10.1016\/j.vaccine.2021.01.032_b0475","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1016\/S1473-3099(16)00129-8","article-title":"Variable influenza vaccine effectiveness by subtype: a systematic review and meta-analysis of test-negative design studies","volume":"16","author":"Belongia","year":"2016","journal-title":"Lancet Infect Dis"},{"issue":"2","key":"10.1016\/j.vaccine.2021.01.032_b0480","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1093\/cid\/cit194","article-title":"Influenza vaccine effectiveness in preventing outpatient, inpatient, and severe cases of laboratory-confirmed influenza","volume":"57","author":"Castilla","year":"2013","journal-title":"Clinical Infect Dis"},{"issue":"14","key":"10.1016\/j.vaccine.2021.01.032_b0485","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1016\/j.vaccine.2016.02.039","article-title":"Influenza vaccine effectiveness by test-negative design \u2013 Comparison of inpatient and outpatient settings","volume":"34","author":"Feng","year":"2016","journal-title":"Vaccine"},{"issue":"12","key":"10.1016\/j.vaccine.2021.01.032_b0490","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1016\/S1473-3099(14)70960-0","article-title":"Effectiveness of seasonal influenza vaccine in community-dwelling elderly people: a meta-analysis of test-negative design case-control studies","volume":"14","author":"Darvishian","year":"2014","journal-title":"Lancet Infect Dis"},{"issue":"5","key":"10.1016\/j.vaccine.2021.01.032_b0495","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.jinf.2017.09.010","article-title":"Effectiveness of influenza vaccines in preventing severe influenza illness among adults: A systematic review and meta-analysis of test-negative design case-control studies","volume":"75","author":"Rondy","year":"2017","journal-title":"J Infect"},{"issue":"3","key":"10.1016\/j.vaccine.2021.01.032_b0500","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1093\/cid\/cit255","article-title":"Stratified Estimates of Influenza Vaccine Effectiveness by Prior Vaccination: Caution Required","volume":"57","author":"Sullivan","year":"2013","journal-title":"Clin Infect Dis"},{"issue":"10","key":"10.1016\/j.vaccine.2021.01.032_b0505","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1093\/cid\/ciu680","article-title":"Impact of Repeated Vaccination on Vaccine Effectiveness Against Influenza A(H3N2) and B During 8 Seasons","volume":"59","author":"McLean","year":"2014","journal-title":"Clin Infect Dis"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X21000487?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X21000487?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:51:32Z","timestamp":1759402292000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X21000487"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2]]},"references-count":101,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2021,2]]}},"alternative-id":["S0264410X21000487"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2021.01.032","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2021,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Variable seasonal influenza vaccine effectiveness across geographical regions, age groups and levels of vaccine antigenic similarity with circulating virus strains: A systematic review and meta-analysis of the evidence from test-negative design studies after the 2009\/10 influenza pandemic","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2021.01.032","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}